Delivery Order SPE2DB25D3006-SPE2DB25FXKMU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count package) valued at $1,277.60 under a firm fixed-price contract type. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order is non-set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this contract, consistent with the...
- The Defense Logistics Agency awarded a delivery order valued at $3,937.76 to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count supply) with a firm fixed price structure. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside procurement. Performance will take place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's $999.9...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of XCOPRI 200 mg tablets (30-count units) valued at $2,127.24. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,768.44, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded delivery order was issued on August 19, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,768.44 delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count supply) under a firm fixed price contract type. The award was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $3,811.64 delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-unit supply) on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical product will be delivered to the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,536.88 delivery order to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count units) with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by June 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count) valued at $1,842.99 under a firm fixed price contract type. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of XCOPRI 50 MG tablets (30-count packages) valued at $7,622.85. This firm fixed-price delivery order represents a non-competitive award and carries an ultimate completion date of August 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,877.45 delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count units) on June 16, 2025, with a completion date of June 17, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXKMUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count) valued at $3,536.88 under a firm fixed-price contract type. The award was made on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a non-competitive delivery order issued without a set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. The company serves as a key vendor for the Defense Health Agency and other federal healthcare systems through this flexible contract vehicle, demonstrating its capability to fulfill diverse federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/19/25 |